4basebio PLC carries a market capitalization of 81.30M, placing it among publicly traded companies globally.
| Market Cap | 81.30M |
| Enterprise Value | N/A |
4basebio PLC's stock has declined approximately -46.70051% over the past 52 weeks. The 50-day moving average sits at 503.73, while the 200-day moving average is 593.81.
| Beta (5Y) | N/A |
| 52-Week Price Change | -46.70051% |
| 50-Day Moving Average | 503.73 |
| 200-Day Moving Average | 593.81 |
| Average Volume (20 Days) | N/A |